SCHEMBL3947503

SCHEMBL3947503

Cn1ncc(Cl)c1-c1cc(NC(=O)COc2ccc(Cl)cc2)ccc1OCCN1CCOCC1

nearest known ligand 0.81

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 19/20 0.81
HTR2C P28335 19/20 0.81
LMNA P02545 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4043358 0.94 HTR2A (0.72) HTR2AHTR2C
SCHEMBL3948351 0.94 HTR2A (0.73) HTR2AHTR2C
SCHEMBL3954910 0.92 HTR2A (0.69) HTR2AHTR2C
SCHEMBL3945712 0.90 HTR2A (0.77) HTR2AHTR2C
SCHEMBL1166098 0.90 HTR2A (0.82) HTR2AHTR2C
SCHEMBL4037569 0.90 HTR2A (0.82) HTR2AHTR2C
SCHEMBL4037589 0.90 HTR2A (0.67) HTR2AHTR2CLMNA
SCHEMBL1165385 0.89 HTR2A (1.00) HTR2AHTR2C
SCHEMBL3954212 0.89 HTR2A (0.69) HTR2AHTR2C
SCHEMBL4037245 0.89 HTR2A (0.69) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP claimed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed